Logo

Companion Medical's InPen Diabetes Management System Receives the US FDA's Approval for Fixed Dosing and Meal Estimation

Share this

Companion Medical's InPen Diabetes Management System Receives the US FDA's Approval for Fixed Dosing and Meal Estimation

Shots:

  • The InPen bolus calculator determines the user’s current glucose level and active insulin to calculate the amount of insulin still lowering glucose from previous bolus doses thus removing the conjecture from insulin dosing
  • The new InPen offers users on fixed-dose or meal estimation therapy an advance solution to maintain blood glucose level and avoid stacking of insulin and minimizing the risk of low glucose. The device is cleared for both T1D & T2D patients who administer insulin for meals or deliver doses based on the approximate size of their planned meal
  • The InPen system includes a smartpen and Bluetooth connected app that aid in calculating insulin doses- issues dose reminders- track active insulin and send reports to caregivers and is available in the US The InPen system includes a smartpen and Bluetooth connected app that aid in calculating insulin doses- issues dose reminders- track active insulin and send reports to caregivers and is available in the US The InPen system includes a smartpen and Bluetooth connected app that aid in calculating insulin doses- issues dose reminders- track active insulin and send reports to caregivers and is available in the US

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: InPen


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions